HCAT Q3 2026 deep dive: client retention and cost alignment take center stage
Health Catalyst, Inc. (HCAT) Q3 2026 Earnings Call Transcript
Health Catalyst Inc (HCAT) (Q3 2026) Earnings Call Highlights: Revenue and EBITDA Beat Guidance ...
Health Catalyst (HCAT) Q3 2026 Earnings Call Transcript
What Health Catalyst (HCAT) Said on Its Q3 Earnings Call
Health Catalyst (HCAT) Reports Q3 Loss, Beats Revenue Estimates
Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings
Health Catalyst (NASDAQ:HCAT) exceeds Q3 2026 expectations
Health Catalyst: Q3 Earnings Snapshot
Health Catalyst Reports Third Quarter 2026 Results
Health Catalyst Q3 2026 Earnings Call Transcript
Health Catalyst Affirms FY2026 Sales Guidance of $246.000M-$249.000M vs $247.804M Est
Health Catalyst Q3 Adj. EPS $(0.03) Beats $(0.05) Estimate, Sales $56.283M Beat $55.390M Estimate
Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
Data Analytics Stocks Q2 Results: Benchmarking Health Catalyst (NASDAQ:HCAT)
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q2 Earnings?
Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Health Catalyst appoints new CEO
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.